Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Winer, Eric
Item TypeName
Academic Article Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
Academic Article American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
Academic Article Quality of life issues among women undergoing high-dose chemotherapy for breast cancer.
Academic Article Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.
Academic Article The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
Academic Article A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181.
Academic Article Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.
Academic Article Trastuzumab/chemotherapy combinations in metastatic breast cancer.
Academic Article Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Academic Article Assessing the cost-effectiveness of postmastectomy radiation therapy.
Academic Article Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis.
Academic Article American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
Academic Article Brain metastases: the HER2 paradigm.
Academic Article Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
Academic Article NCCN Task Force Report: breast cancer in the older woman.
Academic Article Quality of non-breast cancer health maintenance among elderly breast cancer survivors.
Academic Article Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.
Academic Article Fertility after breast cancer: questions abound.
Academic Article Oral 5-FU analogues in the treatment of breast cancer.
Academic Article Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group.
Academic Article Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer.
Academic Article Patient utilities for advanced cancer: effect of current health on values.
Academic Article Economic outcomes of breast cancer survivorship: CALGB study 79804.
Academic Article American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Academic Article Standards for follow-up care of patents with breast cancer.
Academic Article Cancer-related communication between female patients and male partners scale: A pilot study.
Academic Article HER2 testing in breast cancer: NCCN Task Force report and recommendations.
Academic Article Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.
Academic Article Cancer pain survey: patient-centered issues in control.
Academic Article Hormonal therapy in postmenopausal women with breast cancer.
Academic Article Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.
Academic Article NCCN Practice Guidelines for Breast Cancer.
Academic Article Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ.
Academic Article Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey.
Academic Article Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
Academic Article New combinations with Herceptin in metastatic breast cancer.
Academic Article Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840.
Academic Article Follow-up care of patients with breast cancer.
Academic Article Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.
Academic Article Involving family members in cancer care: focus group considerations of patients and oncological providers.
Academic Article Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy.
Academic Article Use of taxanes in the treatment of patients with breast cancer has increased dramatically over the past 8 years.
Academic Article Adherence to therapy with oral antineoplastic agents.
Academic Article Pre-counseling education materials for BRCA testing: does tailoring make a difference?
Academic Article The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries.
Academic Article Offering participants results of a clinical trial: sharing results of a negative study.
Academic Article Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.
Academic Article Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer.
Academic Article Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer.
Academic Article Complementary and alternative medicine use among women with breast cancer.
Academic Article Testing for hereditary breast and ovarian cancer in the southeastern United States.
Academic Article Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer.
Academic Article Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer.
Academic Article Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
Academic Article Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
Academic Article Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
Academic Article Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
Academic Article Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis.
Academic Article Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Academic Article Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations.
Academic Article Ten years of HER2-directed therapy: still questions after all these years.
Academic Article Fertility and menopausal outcomes in young breast cancer survivors.
Academic Article Follow-up care of breast cancer survivors.
Academic Article Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer.
Academic Article Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer.
Academic Article Local therapy and survival in breast cancer.
Academic Article Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804.
Academic Article Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
Academic Article Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.
Academic Article Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.
Academic Article Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial.
Academic Article Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
Academic Article 1st International consensus guidelines for advanced breast cancer (ABC 1).
Academic Article Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.
Academic Article Breast cancer: noninvasive and special situations.
Academic Article Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
Academic Article Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions.
Academic Article Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.
Academic Article Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
Academic Article The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
Academic Article Refining therapy for human epidermal growth factor receptor 2-positive breast cancer: T stands for trastuzumab, tumor size, and treatment strategy.
Academic Article Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea.
Academic Article Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients.
Academic Article Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
Academic Article Case records of the Massachusetts General Hospital. Case 32-2007. A 62-year-old woman with a second breast cancer.
Academic Article Reducing disparities in breast cancer care: a daunting but essential responsibility.
Academic Article The aromatase inhibitors as adjuvant therapy for hormone receptor-positive breast cancer.
Academic Article Protocol for the examination of specimens from patients with invasive carcinoma of the breast.
Academic Article Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.
Academic Article Aromatase inhibition in obese women: how much is enough?
Academic Article Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics.
Academic Article The role of socioeconomic status in adjustment after ductal carcinoma in situ.
Academic Article International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?
Academic Article Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.
Academic Article Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.
Academic Article CMF revisited in the 21st century.
Academic Article Model program to improve care for a unique cancer population: young women with breast cancer.
Academic Article Adjuvant chemotherapy in older women with early-stage breast cancer.
Academic Article Outcomes following local therapy for early-stage breast cancer in non-trial populations.
Academic Article Cardiac toxicity from systemic cancer therapy: a comprehensive review.
Academic Article Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.
Academic Article Overestimation of hereditary breast cancer risk.
Academic Article Liposomal anthracyclines for breast cancer.
Academic Article Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.
Academic Article Informed consent for BRCA1 and BRCA2 testing.
Academic Article Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors.
Academic Article Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
Academic Article Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer.
Academic Article The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
Academic Article Can axillary node dissection be omitted in a subset of patients with low local and regional failure rates?
Academic Article Weight gain in women diagnosed with breast cancer.
Academic Article A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine.
Academic Article Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
Academic Article American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.
Academic Article Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm.
Academic Article New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitors.
Academic Article Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
Academic Article Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.
Academic Article Optimal use of aromatase inhibitors: to lead or to follow?
Academic Article HER2 and response to paclitaxel in node-positive breast cancer.
Academic Article Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Academic Article Implementing an interdisciplinary governance model in a comprehensive cancer center.
Academic Article Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.
Academic Article Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ.
Academic Article Trends in racial and age disparities in definitive local therapy of early-stage breast cancer.
Academic Article Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.
Academic Article Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
Academic Article CNS metastases in breast cancer.
Academic Article Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806.
Academic Article Docetaxel administered on a weekly basis for metastatic breast cancer.
Academic Article Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Academic Article Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer.
Academic Article Web-based survey of fertility issues in young women with breast cancer.
Academic Article Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342.
Academic Article Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.
Academic Article Invasive breast cancer.
Academic Article Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study.
Academic Article Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel.
Academic Article Lymphopenia associated with adjuvant anthracycline/ taxane regimens.
Academic Article Should a sentinel node biopsy be performed in patients with high-risk breast cancer?
Academic Article Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?
Academic Article The use of adjuvant chemotherapy for breast cancer in a community practice.
Academic Article Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.
Academic Article Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Academic Article Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Academic Article Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.
Academic Article Adjuvant chemotherapy in luminal breast cancers.
Academic Article Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data.
Academic Article The impact of sharing results of a randomized breast cancer clinical trial with study participants.
Academic Article Triple-negative breast cancer: risk factors to potential targets.
Academic Article Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.
Academic Article Breast cancer. Clinical practice guidelines in oncology.
Academic Article Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.
Academic Article Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.
Academic Article Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Academic Article American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
Academic Article Triple-negative breast cancer: disease entity or title of convenience?
Academic Article Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus Conference.
Academic Article Survival implications associated with variation in mastectomy rates for early-staged breast cancer.
Academic Article Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
Academic Article Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.
Academic Article Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.
Academic Article Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104.
Academic Article Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer.
Academic Article Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer.
Academic Article Time to diagnosis and breast cancer stage by race/ethnicity.
Academic Article Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial.
Academic Article Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642.
Academic Article American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
Academic Article Lumping versus splitting: the splitters take this round.
Academic Article Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
Academic Article Optimizing endocrine therapy for breast cancer.
Academic Article Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.
Academic Article Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907).
Academic Article Effect of Massachusetts health insurance reform on mammography use and breast cancer stage at diagnosis.
Academic Article Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.
Academic Article Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.
Academic Article Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
Academic Article Do patients participating in clinical trials want to know study results?
Academic Article Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Academic Article Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older.
Academic Article New cytotoxic agents and schedules for advanced breast cancer.
Academic Article Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma.
Academic Article Phase I study of Doxil and vinorelbine in metastatic breast cancer.
Academic Article Primary care for survivors of breast cancer.
Academic Article Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Academic Article Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.
Academic Article Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).
Academic Article Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.
Academic Article Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Academic Article Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
Academic Article A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases.
Academic Article Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
Academic Article HER2 or not HER2: that is the question.
Academic Article Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women.
Academic Article GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays.
Academic Article Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases.
Academic Article PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer.
Academic Article Menopausal-type symptoms in young breast cancer survivors.
Academic Article Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Academic Article On mammography--more agreement than disagreement.
Academic Article Does neoadjuvant bevacizumab increase surgical complications in breast surgery?
Academic Article 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
Academic Article Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study.
Academic Article A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.
Academic Article Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score.
Academic Article Breast cancer survivors' perceptions of survivorship care options.
Academic Article TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.
Academic Article Dose density in breast cancer: a simple message?
Academic Article Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
Academic Article Cost-effectiveness of switching to exemestane after 2 to 3 years of therapy with tamoxifen in postmenopausal women with early-stage breast cancer.
Academic Article Heterogeneity of breast cancer and implications of adjuvant chemotherapy.
Academic Article Phase II evaluation of thalidomide in patients with metastatic breast cancer.
Academic Article American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
Academic Article Clinical differences among the aromatase inhibitors.
Academic Article The natural history of hormone receptor-positive breast cancer.
Academic Article High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.
Academic Article HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.
Academic Article Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.
Academic Article Factors related to underuse of surveillance mammography among breast cancer survivors.
Academic Article NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.
Academic Article Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
Academic Article Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.
Academic Article Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors.
Academic Article Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?
Academic Article Sarcoidosis mimicking metastatic breast cancer.
Academic Article A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.
Academic Article A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
Academic Article Quality of life and symptoms in male breast cancer survivors.
Academic Article Why women gain weight with adjuvant chemotherapy for breast cancer.
Academic Article Silicone controversy: a survey of women with breast cancer and silicone implants.
Academic Article Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions.
Academic Article International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
Academic Article American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities.
Academic Article The effect of age on delay in diagnosis and stage of breast cancer.
Academic Article Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib.
Academic Article p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905).
Academic Article The American Society of Clinical Oncology's Blueprint for Transforming Clinical and Translational Cancer Research.
Academic Article Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?
Academic Article Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.
Academic Article Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer.
Academic Article Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Academic Article Chemotherapy agents in human epidermal growth factor receptor 2-positive breast cancer: time to step out of the limelight.
Academic Article Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.
Academic Article Patterns of bone density evaluation in a community population treated with aromatase inhibitors.
Academic Article Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
Academic Article Long-term complications of adjuvant chemotherapy for early stage breast cancer.
Academic Article The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer.
Academic Article Cancer and leukemia group B breast committee: decades of progress and plans for the future.
Academic Article Surveillance testing among survivors of early-stage breast cancer.
Academic Article Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time.
Academic Article A review of hereditary breast cancer: from screening to risk factor modification.
Academic Article Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
Academic Article Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.
Academic Article Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
Academic Article Further progress in HER2-directed therapy.
Academic Article Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
Academic Article Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants.
Academic Article Ovarian suppression for breast cancer: an effective treatment in search of a home.
Academic Article Quality-of-life research in patients with breast cancer.
Academic Article Care in the months before death and hospice enrollment among older women with advanced breast cancer.
Academic Article Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
Academic Article Advances in adjuvant endocrine therapy for postmenopausal women.
Academic Article Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.
Academic Article Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.
Academic Article Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?
Academic Article Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy.
Academic Article High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine.
Academic Article Breast cancer.
Academic Article Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy.
Academic Article Newer monoclonal antibodies for hematological malignancies.
Academic Article VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
Academic Article Quality of life in long-term survivors of metastatic breast cancer.
Academic Article Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ.
Academic Article Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.
Concept Neoplasms, Glandular and Epithelial
Concept Breast Neoplasms
Concept Bone Neoplasms
Concept Neoplasms, Hormone-Dependent
Concept Head and Neck Neoplasms
Concept Urogenital Neoplasms
Concept Meningeal Neoplasms
Concept Neoplasms, Second Primary
Concept Colorectal Neoplasms
Concept Ovarian Neoplasms
Concept Breast Neoplasms, Male
Concept Mammary Neoplasms, Experimental
Concept Brain Neoplasms
Concept Lung Neoplasms
Concept Gastrointestinal Neoplasms
Concept National Cancer Institute (U.S.)
Concept Neoplasms
Concept Lymphatic Metastasis
Concept Genital Neoplasms, Female
Concept Cancer Care Facilities
Concept Early Detection of Cancer
Concept Central Nervous System Neoplasms
Concept Inflammatory Breast Neoplasms
Concept Soft Tissue Neoplasms
Concept Liver Neoplasms
Concept Endometrial Neoplasms
Concept Prostatic Neoplasms
Concept Neoplasm Metastasis
Concept Hematologic Neoplasms
Academic Article High performance teamwork training and systems redesign in outpatient oncology.
Academic Article A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer.
Academic Article Body image in recently diagnosed young women with early breast cancer.
Academic Article Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship.
Academic Article Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial.
Academic Article Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.
Academic Article Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era.
Academic Article Attitudes of patients with metastatic breast cancer toward research biopsies.
Academic Article Long-term risk perceptions of women with ductal carcinoma in situ.
Academic Article International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer.
Academic Article A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer.
Academic Article A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer.
Academic Article Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.
Academic Article Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study.
Academic Article Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
Academic Article Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care?
Academic Article Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction.
Academic Article Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
Academic Article A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.
Academic Article Pertuzumab: optimizing HER2 blockade.
Academic Article Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.
Academic Article Prospective clinical experience with research biopsies in breast cancer patients.
Academic Article A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases.
Academic Article Reply to P.G. Tsoutsou et al, o. Kaidar-Person et al, and A. Courdi et al.
Academic Article Breast cancer presentation and diagnostic delays in young women.
Academic Article Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancer.
Academic Article Use and duration of chemotherapy in patients with metastatic breast cancer according to tumor subtype and line of therapy.
Academic Article Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer.
Academic Article A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901.
Academic Article A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer.
Academic Article Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study.
Academic Article Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Academic Article Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy.
Academic Article A dickens tale of the treatment of advanced breast cancer: the past, the present, and the future.
Academic Article Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline.
Academic Article Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.
Academic Article Defining success in neoadjuvant breast cancer trials.
Academic Article Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Academic Article Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.
Academic Article TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.
Academic Article Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance).
Academic Article Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors.
Academic Article Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.
Academic Article Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.
Academic Article Male breast cancer networking and telephone support group: a model for supporting a unique population.
Academic Article Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).
Academic Article Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.
Academic Article Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance).
Academic Article ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.
Academic Article ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).
Academic Article Predicting response and survival in chemotherapy-treated triple-negative breast cancer.
Academic Article Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.
Academic Article Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901.
Academic Article Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.
Academic Article Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.
Academic Article Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance).
Academic Article Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
Academic Article Long-term follow-up after preoperative trastuzumab and chemotherapy for HER2-overexpressing breast cancer.
Academic Article Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).
Academic Article Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
Academic Article Surgical Options and Locoregional Recurrence in Patients Diagnosed with Invasive Lobular Carcinoma of the Breast.
Academic Article Adjuvant ovarian suppression in premenopausal breast cancer.
Academic Article Reply to V. Amoroso et al.
Academic Article SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer.
Academic Article Personalization of loco-regional care for primary breast cancer patients (part 1).
Academic Article Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study.
Academic Article Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.
Academic Article Racial differences in outcomes for patients with metastatic breast cancer by disease subtype.
Academic Article Personalization of loco-regional care for primary breast cancer patients (part 2).
Academic Article Tumor-infiltrating lymphocytes and response to platinum in triple-negative breast cancer.
Academic Article TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.
Academic Article Q&A: Eric Winer on neoadjuvant clinical trials.
Academic Article Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
Academic Article Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer.
Academic Article Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Academic Article Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.
Academic Article Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).
Academic Article Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
Academic Article Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).
Academic Article In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.
Academic Article Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer.
Academic Article Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance).
Academic Article Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).
Academic Article Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.
Academic Article Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer.
Academic Article Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer.
Academic Article Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors.
Academic Article Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
Academic Article Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
Academic Article Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.
Academic Article Response.
Academic Article POINT: HER2-Targeted Combinations in Advanced HER2-Positive Breast Cancer.
Academic Article Response.
Academic Article Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
Academic Article Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.
Academic Article Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
Academic Article Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.
Academic Article Timeliness in Breast Cancer Treatment-The Sooner, the Better.
Academic Article Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers.
Academic Article Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.
Academic Article Randomized trial of a physical activity intervention in women with metastatic breast cancer.
Academic Article Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Academic Article Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression.
Academic Article Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases.
Academic Article PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling.
Academic Article Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.
Academic Article Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
Academic Article The Role of Proliferation in Determining Response to Neoadjuvant Chemotherapy in Breast Cancer: A Gene Expression-Based Meta-Analysis.
Academic Article PI3K-p110a mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers.
Academic Article Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer.
Academic Article I-SPY 2--Toward More Rapid Progress in Breast Cancer Treatment.
Academic Article Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).
Academic Article Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
Academic Article Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
Grant Cancer and Leukemia Group B
Grant Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
Grant Dana-Farber/Harvard SPORE in Breast Cancer
Grant Dana-Farber/Harvard Cancer Center
Academic Article Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab.
Academic Article Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival.
Academic Article A Phase Ib Study of Alpelisib (BYL719), a PI3Ka-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer.
Academic Article Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study.
Academic Article Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).
Academic Article Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study.
Academic Article Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
Academic Article Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
Academic Article Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.
Academic Article Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review.
Academic Article 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).
Academic Article Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527.
Academic Article Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].
Academic Article 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).
Academic Article Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
Academic Article Perils of the Pathologic Complete Response.
Academic Article Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study.
Academic Article Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer.
Academic Article 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).
Academic Article Genomic Profiling in Node-Positive ER-Positive Early Breast Cancer: Can Tumor Biology Guide Locoregional Therapy?
Academic Article Reply to S. Sorscher.
Academic Article Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).
Academic Article Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.
Academic Article De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Academic Article CDK4/6 inhibition triggers anti-tumour immunity.
Academic Article Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design.
Academic Article Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.
Academic Article Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is Underway.
Academic Article Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.
Academic Article Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.
Academic Article Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations.
Academic Article Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
Academic Article Breast cancer-specific survival by age: Worse outcomes for the oldest patients.
Academic Article De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Academic Article Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer.
Academic Article Predicting breast cancer therapeutic response.
Academic Article Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Academic Article Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.
Academic Article Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update.
Academic Article 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.
Academic Article Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.
Academic Article CDK4/6 inhibition in breast cancer: current practice and future directions.
Academic Article Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer.
Academic Article Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.
Academic Article Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies.
Academic Article TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.
Academic Article The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial.
Academic Article TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
Academic Article Olaparib and a-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial.
Academic Article Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
Academic Article Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Academic Article Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study.
Academic Article The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.
Academic Article Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial.
Academic Article A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma.
Academic Article Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation.
Academic Article Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
Academic Article Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
Academic Article A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases.
Academic Article Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.
Academic Article Aggressive Subsets of Metastatic Triple Negative Breast Cancer.
Academic Article Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer.
Academic Article Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
Academic Article Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer.
Academic Article Prevalence and mutational determinants of high tumor mutation burden in breast cancer.
Academic Article TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial).
Academic Article A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer.
Academic Article Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer.
Academic Article Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer.
Academic Article The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
Academic Article Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases.
Academic Article Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
Academic Article Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond.
Academic Article Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).
Academic Article Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.
Academic Article Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.
Academic Article Therapy for HER2-Positive Metastatic Breast Cancer. Reply.
Academic Article Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
Academic Article Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.
Academic Article Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
Academic Article Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study.
Academic Article Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab.
Academic Article Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers.
Academic Article Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer.
Academic Article Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy.
Academic Article TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker.
Academic Article A Food and Drug Administration analysis of survival outcomes comparing the Adjuvant Paclitaxel and Trastuzumab trial with an external control from historical clinical trials.
Academic Article Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial.
Academic Article Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center.
Academic Article Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials.
Academic Article 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).
Academic Article A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer.
Academic Article Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer.
Academic Article TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Academic Article Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer.
Academic Article Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer.
Academic Article Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases.
Academic Article Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer.
Academic Article Perceptions of patients with early stage breast cancer toward research biopsies.
Academic Article Genomic Characterization of de novo Metastatic Breast Cancer.
Academic Article Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
Academic Article The Global Landscape of Treatment Standards for Breast Cancer.
Academic Article Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement.
Academic Article Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer.
Academic Article Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry.
Academic Article Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer.
Academic Article Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study.
Academic Article Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer.
Academic Article Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer.
Academic Article Breast cancer: T-DM1 - an important agent in the history of breast cancer management.
Academic Article Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial.
Academic Article Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Academic Article Passion for immune checkpoint blockade in triple negative breast cancer: Comment on the IMpassion130 study.
Academic Article A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB).
Academic Article Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study.
Academic Article A Phase 1 Dose-Escalation Trial of Radiation Therapy and Concurrent Cisplatin for Stage II and III Triple-Negative Breast Cancer.
Academic Article Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19.
Academic Article Factors associated with late risks of breast cancer-specific mortality in the SEER registry.
Academic Article The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.
Academic Article Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab.
Academic Article Genomic features of rapid versus late relapse in triple negative breast cancer.
Academic Article Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.
Academic Article Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast Cancer.
Academic Article Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.
Academic Article Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.
Academic Article Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance).
Academic Article Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.
Academic Article PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.
Academic Article Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Academic Article Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
Academic Article Correction to: Factors associated with late risks of breast cancer-specific mortality in the SEER registry.
Academic Article First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis.
Academic Article Corrigendum to 'First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis': Annals of Oncology 2021; volume 32: 983-993.
Academic Article Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.
Academic Article Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study.
Academic Article Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer.
Academic Article How we treat HER2-positive brain metastases.
Academic Article Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer.
Search Criteria
  • Cancer
  • metastasis
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.